{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:38:24Z","timestamp":1791049104027,"version":"4.1.0"},"reference-count":102,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00169","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T03:51:39Z","timestamp":1499917899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Autoimmune Thyroiditis and Myasthenia Gravis"],"prefix":"10.3389","volume":"8","author":[{"given":"Angela","family":"Lopomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"4","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2265.2010.03855.x","article-title":"Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum","volume":"74","author":"Weetman","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fendo.2017.00092","article-title":"Hashimoto\u2019s thyroiditis and autoimmune gastritis","volume":"8","author":"Cellini","year":"2017","journal-title":"Front Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3803\/EnM.2016.31.4.493","article-title":"Clinical update in aspects of the management of autoimmune thyroid diseases","volume":"31","author":"Topliss","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-0036-1586265","article-title":"Myasthenia gravis","volume":"36","author":"Drachman","year":"2016","journal-title":"Semin Neurol"},{"key":"B10","first-page":"3611","article-title":"Autoimmune thyroid disease: mechanism, genetics and current knowledge","volume":"18","author":"Dong","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis\u2014autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/00207454.2010.539307","article-title":"Frequency of autoimmune diseases in myasthenia gravis: a systematic review","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1002\/brb3.537","article-title":"Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course","volume":"6","author":"Kubiszewska","year":"2016","journal-title":"Brain Behav"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.humimm.2013.06.020","article-title":"Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis","volume":"74","author":"Klein","year":"2013","journal-title":"Hum Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1468-1331.2004.00968.x","article-title":"Associated conditions in myasthenia gravis: response to thymectomy","volume":"11","author":"Tellez-Zenteno","year":"2004","journal-title":"Eur J Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/BF03346432","article-title":"Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders","volume":"31","author":"Nakamura","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1600-0404.2012.01693.x","article-title":"Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan","volume":"127","author":"Chen","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"B19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jnnp.2008.167163","article-title":"When to consider thyroid dysfunction in the neurology clinic","volume":"9","author":"Mistry","year":"2009","journal-title":"Pract Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","article-title":"Complicating autoimmune diseases in myasthenia gravis: a review","volume":"48","author":"Nacu","year":"2015","journal-title":"Autoimmunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1210\/jc.2011-1568","article-title":"Innate immune activation and thyroid autoimmunity","volume":"96","author":"Kawashima","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cen.12066","article-title":"Selenium and the thyroid gland: more good news for clinicians","volume":"78","author":"Drutel","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1210\/jc.2005-1366","article-title":"High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity","volume":"90","author":"Brix","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e29646","DOI":"10.1371\/journal.pone.0029646","article-title":"Fetal microchimeric cells in blood of women with an autoimmune thyroid disease","volume":"6","author":"Lepez","year":"2011","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential estrogen receptor expression in autoimmune myasthenia gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI81894","article-title":"Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases","volume":"126","author":"Dragin","year":"2016","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/kel170","article-title":"The PTPN22 C1858T functional polymorphism and autoimmune diseases\u2014a meta-analysis","volume":"46","author":"Lee","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrendo.2013.56","article-title":"GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis","volume":"9","author":"Simmonds","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis\u2014a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J Autoimmun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","article-title":"The etiology of autoimmune thyroid disease: a story of genes and environment","volume":"32","author":"Tomer","year":"2009","journal-title":"J Autoimmun"},{"key":"B31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF03401317","article-title":"Thyroid involvement in hepatitis C\u2014associated mixed cryoglobulinemia","volume":"13","author":"Fallahi","year":"2014","journal-title":"Hormones (Athens)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/thy.2012.0264","article-title":"Inflammation and increased myxovirus resistance protein A expression in thyroid tissue in the early stages of Hashimoto\u2019s thyroiditis","volume":"23","author":"Hammerstad","year":"2013","journal-title":"Thyroid"},{"key":"B33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11154-016-9361-4","article-title":"The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders","volume":"17","author":"Fallahi","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"B34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1210\/jc.2016-3403","article-title":"Hepatitis C virus E2 protein induces upregulation of IL-8 pathways and production of heat shock proteins in human thyroid cells","volume":"102","author":"Hammerstad","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"50.e51","DOI":"10.1016\/j.cmi.2016.09.023","article-title":"Association of active human herpesvirus-6 (HHV-6) infection with autoimmune thyroid gland diseases","volume":"23","author":"Sultanova","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"B36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mus.22103","article-title":"The thymus in myasthenia gravis: site of \u201cinnate autoimmunity\u201d?","volume":"44","author":"Cavalcante","year":"2011","journal-title":"Muscle Nerve"},{"key":"B38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J Autoimmun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","article-title":"Increased expression of toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection","volume":"221","author":"Cavalcante","year":"2016","journal-title":"Immunobiology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.imbio.2016.06.012","article-title":"A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients","volume":"221","author":"Barzago","year":"2016","journal-title":"Immunobiology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am J Pathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2008.06.028","article-title":"Thymus and Myasthenia gravis: what can we learn from DNA microarrays?","volume":"20","author":"Cizeron-Clairac","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaut.2013.04.002","article-title":"Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways","volume":"44","author":"Hasham","year":"2013","journal-title":"J Autoimmun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.4049\/jimmunol.1002631","article-title":"IFN-alpha mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms","volume":"186","author":"Akeno","year":"2011","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jnnp.2003.028233","article-title":"Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment","volume":"75","author":"Dionisiotis","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.016","article-title":"Central role of interferon-beta in thymic events leading to myasthenia gravis","volume":"52","author":"Cufi","year":"2014","journal-title":"J Autoimmun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMe1205943","article-title":"Tumor immunotherapy directed at PD-1","volume":"366","author":"Ribas","year":"2012","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1530\/ERC-13-0499","article-title":"Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution","volume":"21","author":"Ryder","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri750","article-title":"Autoimmune thyroid disease: new models of cell death in autoimmunity","volume":"2","author":"Stassi","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B55","first-page":"B5177","article-title":"Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls","volume":"63","author":"Kristensen","year":"2016","journal-title":"Dan Med J"},{"key":"B56","first-page":"6677","article-title":"Thyroid dysfunction: an autoimmune aspect","volume":"8","author":"Khan","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-0035-1548832","article-title":"The pathogenesis of Hashimoto\u2019s thyroiditis: further developments in our understanding","volume":"47","author":"Ajjan","year":"2015","journal-title":"Horm Metab Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.04.012","article-title":"BREG cells in Hashimoto\u2019s thyroiditis isolated or associated to further organ-specific autoimmune diseases","author":"Santaguida","year":"2017","journal-title":"Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/WCO.0b013e328364d6cd","article-title":"Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation","volume":"26","author":"Le Panse","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/cen3.12319","article-title":"Role of the thymus in autoimmune myasthenia gravis","volume":"7","author":"Berrih-Aknin","year":"2016","journal-title":"Clin Exp Neuroimmunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000452623","article-title":"Immunoglobulin G4-related thyroid diseases","volume":"5","author":"Kottahachchi","year":"2016","journal-title":"Eur Thyroid J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","article-title":"The expanding field of IgG4-mediated neurological autoimmune disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1210\/jcem-69-1-49","article-title":"Development of spontaneous hypothyroidism in patients with Graves\u2019 disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients","volume":"69","author":"Tamai","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/joa.12034","article-title":"The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis","volume":"224","author":"Koneczny","year":"2014","journal-title":"J Anat"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0179-6","article-title":"IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis","volume":"3","author":"Maurer","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"B68","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical review: clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.autrev.2014.01.013","article-title":"Diagnosis and classification of Graves\u2019 disease","volume":"13","author":"Menconi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/thy.2007.0208","article-title":"The role of apoptosis in thyroid autoimmunity","volume":"17","author":"Wang","year":"2007","journal-title":"Thyroid"},{"key":"B72","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0002-9440(10)61762-2","article-title":"Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers","volume":"159","author":"Armengol","year":"2001","journal-title":"Am J Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035 cases and a critical review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni0901-769","article-title":"Determinants of autoimmune thyroid disease","volume":"2","author":"Weetman","year":"2001","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM199607113350206","article-title":"Chronic autoimmune thyroiditis","volume":"335","author":"Dayan","year":"1996","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0008-8749(89)90085-3","article-title":"Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis","volume":"122","author":"Flynn","year":"1989","journal-title":"Cell Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/eji.1830220631","article-title":"T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls","volume":"22","author":"Sun","year":"1992","journal-title":"Eur J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0896-8411(91)90013-3","article-title":"T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity","volume":"4","author":"Berrih-Aknin","year":"1991","journal-title":"J Autoimmun"},{"key":"B79","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.4049\/jimmunol.140.6.1830","article-title":"Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides","volume":"140","author":"Fujii","year":"1988","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1096\/fj.01-0072com","article-title":"Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18","volume":"15","author":"Im","year":"2001","journal-title":"FASEB J"},{"key":"B82","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.4049\/jimmunol.164.10.5236","article-title":"Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL\/6 mice","volume":"164","author":"Karachunski","year":"2000","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/08916930903518081","article-title":"Development of novel therapies for MG: studies in animal models","volume":"43","author":"Souroujon","year":"2010","journal-title":"Autoimmunity"},{"key":"B84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-alpha","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J Autoimmun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"986789","DOI":"10.1155\/2013\/986789","article-title":"Th17\u2009cells in immunity and autoimmunity","volume":"2013","author":"Bedoya","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/eji.201445064","article-title":"IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis","volume":"45","author":"Schaffert","year":"2015","journal-title":"Eur J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/jc.2009-1719","article-title":"Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis","volume":"95","author":"Figueroa-Vega","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves\u2019 disease","volume":"186","author":"Mao","year":"2011","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2012.0514","article-title":"Impairment of regulatory T-cell function in autoimmune thyroid disease","volume":"23","author":"Glick","year":"2013","journal-title":"Thyroid"},{"key":"B92","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000452541","article-title":"Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases","volume":"40","author":"Li","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/mus.23951","article-title":"Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis","volume":"49","author":"Sun","year":"2014","journal-title":"Muscle Nerve"},{"key":"B95","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrgastro.2012.145","article-title":"The gut microbiota-a clinical perspective on lessons learned","volume":"9","author":"Shanahan","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nri1373","article-title":"Interactions between commensal intestinal bacteria and the immune system","volume":"4","author":"Macpherson","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12020-014-0509-2","article-title":"Does microbiota composition affect thyroid homeostasis?","volume":"49","author":"Virili","year":"2015","journal-title":"Endocrine"},{"key":"B99","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00284-014-0640-6","article-title":"Gut microbe analysis between hyperthyroid and healthy individuals","volume":"69","author":"Zhou","year":"2014","journal-title":"Curr Microbiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25597","article-title":"Rituximab treatment of myasthenia gravis: a systematic review","author":"Tandan","year":"2017","journal-title":"Muscle Nerve"},{"key":"B101","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1586\/17512433.2016.1157468","article-title":"Novel therapies for thyroid autoimmune diseases","volume":"9","author":"Fallahi","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in Myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00169\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T12:44:54Z","timestamp":1719319494000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00169\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":102,"alternative-id":["10.3389\/fendo.2017.00169"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00169","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,13]]},"article-number":"169"}}